The George Washington University has sold a portion of its royalty rights to sales of a drug originally developed at the School of Medicine and Health Sciences.
A new survey published in the Journal of Drugs in Dermatology identifies several barriers that prevent the consistent use of fungal diagnostic preparations to correctly identify cutaneous fungal infections.
The GW School of Medicine and Health Sciences is pleased to announce a new Doctor of Health Sciences Program in Leadership in Clinical Practice and Education. The program will be housed within the Department of Health, Human Function, and Rehabilitation Sciences.
The GW Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma. The study is led by Vishal A. Patel, MD, FAAD, FACMS, director of the Cutaneous Oncology Program at the GW Cancer Center.
The GW is pleased to announce that the GW Biorepository is now a core facility. Housed at the GW School of Medicine and Health Sciences, the GW Biorepository received designation as a shared resource available to all GW investigators and is accredited by the College of American Pathologists.
In the early days of medicine, it was unclear whether hypertension was a condition that needed to be treated, or if, as many physicians believed, hypertension might actually be a positive condition. It wasn’t until the 1940s and 50s, according to Stephen Textor, MD, professor of medicine in the...
